Bellerophon Therapeutics CEO and Key Executive Team

• Peter Fernandes

  Chief Executive Officer and Chief Regulatory, Safety & Quality Officer
• Martin Dekker

  Vice President, Engineering and Manufacturing
• Scott P. Bruder

  Director
• Mary Ann Cloyd

  Director
• Crispin Teufel

  Director
• Ted Wang

  Director
• Naseem Amin

  Chairman
• Parag Shah

  Vice President, Business Operations
• Bobae Kim

  Vice President, Regulatory Affairs and Quality Assurance

Source: investors.bellerophon.com, investors.bellerophon.com, bellerophon.com